On July 30, 2024, Pfizer Inc. released its financial results for the second quarter of 2024. The announcement was made through a press release, which is now available as Exhibit 99. This information, while furnished to the Securities and Exchange Commission (SEC) in a Form 8-K filing, is not considered filed for Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into any of Pfizer's other filings, unless explicitly stated. The press release provides detailed insights into Pfizer's operational and financial performance for the quarter.

On July 30, 2024, Pfizer Inc. released its financial results for the second quarter of 2024. The announcement was made through a press release, which is now available as Exhibit 99. This information, while furnished to the Securities and Exchange Commission (SEC) in a Form 8-K filing, is not considered filed for Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into any of Pfizer's other filings, unless explicitly stated. The press release provides detailed insights into Pfizer's operational and financial performance for the quarter.